Explanation of the difference between the self -closing declarations of related party transactions and the audited review by CPA for the fourth quarter of 2021
· Issued by Center Laboratories, Inc.
Close
Today's Information
Provided by: Center Laboratories, Inc.
SEQ_NO
1
Date of announcement
2022/04/13
Time of announcement
18:17:40
Subject
Explanation of the difference between the self
-closing declarations of related party transactions and
the audited review by CPA for the fourth quarter of 2021
Date of events
2022/04/13
To which item it meets
paragraph 53
Statement
1.Date of occurrence of the event:2022/04/13
2.Company name:CENTER LABORATORIES,INC.
3.Relationship to the Company (please enter "head office" or
"subsidiaries"):head office
4.Reciprocal shareholding ratios:NA
5.Cause of occurrence:
In the fourth quarter of 2021, the assets acquired by the company's
related parties were $0, and the financial audit was $86,880,000.
This was due to the company's accountant's justification on CS02
diabetes new drug for China market authorization obtained in 2021.
This equity was acquired by a 100%-owned subsidiary company,
Centerlab Investment Holding Limited, and directly invested in
Guangdong PinSheng Pharmaceutical Technology Co., Ltd., considering
RMB 20,000,000 (NTD$86,880,000).
6.Countermeasures:
To report the reasons for the discrepancies on the Market Observation
Post System under the section of 「Explanation of the numerals
differences between the filing of related parties transaction and
audit review by an accountant」.
7.Any other matters that need to be specified:None
